These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36299888)

  • 1. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 2. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
    Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
    Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
    Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
    Zhang J; Wang Y; Ma J; Aimudula A
    Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
    Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
    Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma.
    Cai T; Wang N; Meng P; Sun W; Cui Y
    Front Genet; 2022; 13():1058040. PubMed ID: 36685888
    [No Abstract]   [Full Text] [Related]  

  • 14. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
    Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
    Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis.
    Lei P; Zhang M; Li Y; Wang Z
    Front Genet; 2023; 14():996362. PubMed ID: 36999057
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study.
    Chu J; Liu W; Hu X; Zhang H; Jiang J
    Health Sci Rep; 2023 Dec; 6(12):e1646. PubMed ID: 38045624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.